Mesenchymal stem cells (MSCs) are multipotent structures that can differentiate into different types of connective tissue cells (chondrocytes, osteocytes, adipocytes). They have strong regenerative properties and are used in regenerative medicine.
The amniotic membrane is the inner layer of the placenta that surrounds the fetus during pregnancy. It is rich in mesenchymal stem cells, which have a high potential for tissue repair.
Characteristics of MSCs from placental amniotic membrane include:
Possible applications of placental MSCs:
Placental MSCs are a promising tool in regenerative medicine due to their strong regenerative properties and safety.
Mesenchymal stem cells (MSCs) are multipotent stem cells capable of differentiating into various connective tissue cells, such as chondrocytes, osteocytes, and adipocytes. They are widely used in regenerative medicine due to their strong repair and healing properties.
The amniotic membrane is the inner layer of the placenta that surrounds and protects the fetus during pregnancy. It is a rich and safe source of mesenchymal stem cells with high regenerative potential.
Placental MSCs are characterized by high proliferative capacity, multipotency, strong anti-inflammatory and immunomodulatory effects, low immunogenicity, and ethical safety, as they are obtained without harm to the mother or child.
MSCs from the amniotic membrane support tissue regeneration by differentiating into damaged cell types, reducing inflammation, modulating immune responses, and stimulating natural repair processes in affected organs and tissues.
Placental MSCs have low immunogenicity, meaning they do not provoke strong immune reactions or rejection. In addition, their collection from the amniotic membrane does not involve invasive procedures and meets ethical standards.
Placental MSCs are used in neurology, orthopedics, dermatology, ophthalmology, cardiology, hepatology, and immunology, including conditions such as stroke, joint degeneration, burns, autoimmune diseases, and liver cirrhosis.
Due to their immunomodulatory properties, MSCs from the amniotic membrane can suppress excessive immune activity, reduce inflammation, and support tissue repair in autoimmune conditions such as rheumatoid arthritis and lupus.
Yes. Placental MSCs can differentiate into chondrocytes and osteocytes, making them suitable for cartilage regeneration in arthrosis and osteoarthritis, as well as bone tissue repair after injuries.
Placental MSCs are studied and applied in neurological conditions such as stroke, spinal cord injury, Parkinson’s disease, and multiple sclerosis, where they may support nerve repair and reduce inflammation.
Placental MSCs are considered promising because they combine strong regenerative capacity, immune regulation, safety, ethical acceptability, and wide applicability across multiple medical specialties.
Україна, Київ вул.Володимирська 11
+38 (099) 111-22-33
info@gmail.com
Графік роботи: 9:00 – 17:00
Субота 09:00 – 13:00
